AR099443A1 - Composición farmacéutica a base de cloroprocaína para la administración intratecal repetida - Google Patents
Composición farmacéutica a base de cloroprocaína para la administración intratecal repetidaInfo
- Publication number
- AR099443A1 AR099443A1 ARP130104578A ARP130104578A AR099443A1 AR 099443 A1 AR099443 A1 AR 099443A1 AR P130104578 A ARP130104578 A AR P130104578A AR P130104578 A ARP130104578 A AR P130104578A AR 099443 A1 AR099443 A1 AR 099443A1
- Authority
- AR
- Argentina
- Prior art keywords
- chloroprocaine
- repeated
- pharmaceutical composition
- administration
- based pharmaceutical
- Prior art date
Links
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 title abstract 3
- 229960002023 chloroprocaine Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010002091 Anaesthesia Diseases 0.000 abstract 3
- 230000037005 anaesthesia Effects 0.000 abstract 3
- 238000007913 intrathecal administration Methods 0.000 abstract 3
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010029350 Neurotoxicity Diseases 0.000 abstract 1
- 206010044221 Toxic encephalopathy Diseases 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007135 neurotoxicity Effects 0.000 abstract 1
- 231100000228 neurotoxicity Toxicity 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición farmacéutica inyectable a base de cloroprocaina o sus sales y/o derivados para el uso en anestesia locorregional central mediante la administración intratecal con dosis repetidas. En forma inesperada, la administración de dosis repetidas de cloroprocaina no aumenta en manera estadísticamente significativa la neurotoxicidad de este fármaco. Reivindicación 8: Una composición según una de las reivindicaciones 1 - 7 (cualquiera de ellas), para el uso en anestesia locorregional central en combinación con adrenalina mediante la administración intratecal con dosis repetidas. Reivindicación 9: Una composición según una de las reivindicaciones 1 - 8 (cualquiera de ellas), para el uso en anestesia locorregional central en combinación con un fármaco analgésico mediante la administración intratecal con dosis repetidas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002120A ITMI20122120A1 (it) | 2012-12-12 | 2012-12-12 | Composizione farmaceutica a base di cloroprocaina per la somministrazione intratecale ripetuta |
Publications (1)
Publication Number | Publication Date |
---|---|
AR099443A1 true AR099443A1 (es) | 2016-07-27 |
Family
ID=47633206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130104578A AR099443A1 (es) | 2012-12-12 | 2013-12-09 | Composición farmacéutica a base de cloroprocaína para la administración intratecal repetida |
Country Status (16)
Country | Link |
---|---|
US (1) | US9504666B2 (es) |
KR (1) | KR102162587B1 (es) |
CN (1) | CN105283222A (es) |
AR (1) | AR099443A1 (es) |
AU (1) | AU2013356855B2 (es) |
IL (1) | IL239270B (es) |
IT (1) | ITMI20122120A1 (es) |
MX (1) | MX2015007288A (es) |
MY (1) | MY180957A (es) |
NZ (1) | NZ709631A (es) |
PH (1) | PH12015501313A1 (es) |
RU (1) | RU2648823C2 (es) |
SG (1) | SG11201504572WA (es) |
UA (1) | UA115078C2 (es) |
WO (1) | WO2014091420A1 (es) |
ZA (1) | ZA201504618B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494310A (zh) * | 2020-04-29 | 2020-08-07 | 周晓玲 | 一种局部麻醉药物的制备及使用方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1572218A4 (en) * | 2002-12-20 | 2007-05-16 | Univ Leland Stanford Junior | LOCAL ANESTHETICS WITH ESTER COMBINATION |
ITMI20051633A1 (it) * | 2005-09-06 | 2007-03-07 | Sint Sa | Nuovo uso di una composizione comprendente cloroprocaina hcl nuova composizione comprendente cloroprocaina hcl e metodo per la sua fabbricazione |
-
2012
- 2012-12-12 IT IT002120A patent/ITMI20122120A1/it unknown
-
2013
- 2013-12-09 AR ARP130104578A patent/AR099443A1/es unknown
- 2013-12-11 US US14/650,583 patent/US9504666B2/en active Active
- 2013-12-11 RU RU2015128024A patent/RU2648823C2/ru active
- 2013-12-11 CN CN201380065146.8A patent/CN105283222A/zh active Pending
- 2013-12-11 MX MX2015007288A patent/MX2015007288A/es unknown
- 2013-12-11 NZ NZ709631A patent/NZ709631A/en unknown
- 2013-12-11 SG SG11201504572WA patent/SG11201504572WA/en unknown
- 2013-12-11 KR KR1020157018300A patent/KR102162587B1/ko active IP Right Grant
- 2013-12-11 WO PCT/IB2013/060801 patent/WO2014091420A1/en active Application Filing
- 2013-12-11 UA UAA201506088A patent/UA115078C2/uk unknown
- 2013-12-11 MY MYPI2015701905A patent/MY180957A/en unknown
- 2013-12-11 AU AU2013356855A patent/AU2013356855B2/en active Active
-
2015
- 2015-06-07 IL IL239270A patent/IL239270B/en active IP Right Grant
- 2015-06-09 PH PH12015501313A patent/PH12015501313A1/en unknown
- 2015-06-25 ZA ZA2015/04618A patent/ZA201504618B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL239270A0 (en) | 2015-07-30 |
SG11201504572WA (en) | 2015-07-30 |
MY180957A (en) | 2020-12-14 |
AU2013356855A1 (en) | 2015-07-23 |
UA115078C2 (uk) | 2017-09-11 |
PH12015501313B1 (en) | 2015-08-24 |
IL239270B (en) | 2018-03-29 |
KR20150085131A (ko) | 2015-07-22 |
WO2014091420A1 (en) | 2014-06-19 |
KR102162587B1 (ko) | 2020-10-08 |
MX2015007288A (es) | 2015-09-10 |
ZA201504618B (en) | 2019-01-30 |
RU2015128024A (ru) | 2017-01-18 |
CN105283222A (zh) | 2016-01-27 |
ITMI20122120A1 (it) | 2014-06-13 |
AU2013356855B2 (en) | 2018-02-15 |
US9504666B2 (en) | 2016-11-29 |
RU2648823C2 (ru) | 2018-03-28 |
NZ709631A (en) | 2020-03-27 |
US20150320716A1 (en) | 2015-11-12 |
PH12015501313A1 (en) | 2015-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123571T1 (el) | Βουπροπιονη για τη ρυθμιση των φαρμακευτικων επιπεδων δεξτρομεθορφανης στο πλασμα | |
CY1123675T1 (el) | Πολυαιθυλενογλυκολιωμενου φαρμακου-συνδετες για βελτιωμενες φαρμακοκινητικες προϊοντος συζευξης προσδετη-φαρμακου | |
NI201600115A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
CR20160237A (es) | Derivados de la carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
NI201600018A (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
NI201500029A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b. | |
CL2015002164A1 (es) | Formulación combinada de dos compuesos antivirales. | |
CL2013003313A1 (es) | Compuestos derivados de 2,4-diaminoquinazolinas, sales o solvatos farmacéuticamente aceptables; composición farmacéutica que los comprende; y uso en el tratamiento de un trastorno en el que interviene la modulación de tlr7 y/o tlr8. | |
ECSP19021223A (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo | |
CL2015003690A1 (es) | Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington. | |
CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
UY35573A (es) | Derivados de sulfamoilpirrolamida y su uso como m edicamentos para el tratamiento de la hepatitis b | |
BR112018002342A2 (pt) | polímeros furtivos intrinsecamente desordenados e geneticamente modificados para entrega e métodos para uso dos mesmos | |
UY34775A (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis múltiple | |
EA201491039A1 (ru) | Комбинации диацереина и нестероидных противовоспалительных лекарственных средств | |
BR112014002025A2 (pt) | partículas que compreendem compostos ativos com base em poliacrilato | |
CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
UY34931A (es) | ?formulación compuesta para administración oral que comprende metformina y rosuvastatina?. | |
ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
AR099443A1 (es) | Composición farmacéutica a base de cloroprocaína para la administración intratecal repetida | |
BR112013024196A2 (pt) | complexos de gálio, composições farmacêuticas e métodos de uso | |
CL2015003679A1 (es) | Agentes terapéuticos para el uso en la profilaxis y/o el tratamiento de trastornos del movimiento hiperquineticoico | |
ECSP16005208A (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
CY1118117T1 (el) | Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |